Comment "AFFILIATE" below, and we'll send you the details
Hidese S, Ogawa S, Ota M, et al
In this study, the putative gshF from A
Important Note on the Evidence Base Important note on the evidence base: The clinical evidence on the IGF-1 axis derives largely from trials of recombinant human IGF-1 (rhIGF-1, sold as mecasermin / Increlex), which is FDA-approved for severe primary IGF-1 deficiency in pediatric patients
J., and Lake, B
For this purpose, RAW 264.7 cells, a macrophage cell line obtained from a male mouse tumor induced with Abelson murine leukemia virus, were plated in complete DMEM (Euroclone) supplemented with 10% FBS in 48-well plates at a density of 2 10 5 cells per well